USD 0.0
(0.0%)
Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|
Revenue | 900.51 Thousand | 844.12 Thousand | - | - | - | - |
Cost of Revenue | 43.21 Thousand | 4.95 Million | - | - | - | - |
Gross Profit | 857.3 Thousand | -4.1 Million | - | - | - | - |
Operating Expenses | 4.94 Million | 6.48 Million | 450.1 Thousand | 35.64 Thousand | 32.63 Thousand | 34.13 Thousand |
Selling, General and Administrative Expenses | 3.69 Million | 6.05 Million | 498.47 Thousand | 35.64 Thousand | 32.63 Thousand | 34.13 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 1.24 Million | -434.17 Thousand | 48.36 Thousand | - | - | - |
Cost and Expenses | 4.94 Million | 11.44 Million | 450.1 Thousand | 35.64 Thousand | 32.63 Thousand | 34.13 Thousand |
Operating Income | -4.04 Million | -10.59 Million | -450.1 Thousand | -35.65 Thousand | -32.63 Thousand | -34.13 Thousand |
Interest Expense | 374.71 Thousand | 295.01 Thousand | 9911.91 | 16.2 Thousand | - | - |
Income Tax Expense | -4.02 | -25.68 Thousand | - | - | - | - |
Earnings before Tax | -5.65 Million | -19.69 Million | -635.32 Thousand | -52.27 Thousand | -45.95 Thousand | -43.29 Thousand |
Net Income | -5.65 Million | -19.69 Million | -635.32 Thousand | -52.27 Thousand | -45.95 Thousand | -43.29 Thousand |
Earnings Per Share Basic | -0.06 | -0.26 | -0.05 | -0.06 | - | - |
Earnings Per Share Diluted | -0.06 | -0.26 | -0.05 | -0.06 | - | - |
Weighted Average Shares Outstanding | 99.92 Million | 75.99 Million | 12.35 Million | 918.05 Thousand | - | - |
Weighted Average Shares Outstanding (Diluted) | 99.92 Million | 75.99 Million | 12.35 Million | 918.05 Thousand | - | - |
Gross Margin | 0.95 | -4.87 | - | - | - | - |
EBIT Margin | -5.13 | -10.71 | - | - | - | - |
Profit Margin | -6.28 | -23.33 | - | - | - | - |
EBITDA | -4.62 Million | -9.04 Million | -450.1 Thousand | -35.65 Thousand | -32.63 Thousand | -34.13 Thousand |
Earnings Before Tax Margin | -4.49 | -12.55 | - | - | - | - |
Breakdown | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 FY | 2020 Q3 |
---|---|---|---|---|---|---|
Revenue | 308.87 Thousand | 273.92 Thousand | 303.13 Thousand | 115.04 Thousand | 943.72 Thousand | 281.47 Thousand |
Cost of Revenue | 4445.00 | -4250.00 | 6860.00 | -159.52 Thousand | 43.21 Thousand | 90.98 Thousand |
Gross Profit | 304.43 Thousand | 278.17 Thousand | 296.27 Thousand | 274.56 Thousand | 900.51 Thousand | 190.49 Thousand |
Operating Expenses | 335.06 Thousand | 1.15 Million | 522.12 Thousand | 2.76 Million | 4.79 Million | 636.16 Thousand |
Selling, General and Administrative Expenses | 335.06 Thousand | 716.23 Thousand | 522.12 Thousand | 2.01 Million | - | 285.46 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | -441.11 Thousand | - | - | -113.39 Thousand | - |
Cost and Expenses | 712.59 Thousand | 1.36 Million | 678.51 Thousand | 2.6 Million | 5.72 Million | 727.14 Thousand |
Operating Income | -403.71 Thousand | -1.09 Million | -375.37 Thousand | -1.93 Million | -4.78 Million | -519.05 Thousand |
Interest Expense | 94.33 Thousand | 60.18 Thousand | 61.37 Thousand | - | 374.71 Thousand | 73.38 Thousand |
Income Tax Expense | -3.00 | 4.00 | - | -270.2 Thousand | -4.02 | 73.38 Thousand |
Earnings before Tax | -499.43 Thousand | -1.15 Million | -1.04 Million | -3.39 Million | -5.93 Million | -337.48 Thousand |
Net Income | -499.43 Thousand | -1.15 Million | -1.04 Million | -3.39 Million | -5.93 Million | -337.48 Thousand |
Earnings Per Share Basic | -0.00 | -0.01 | -0.01 | - | - | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.01 | -0.01 | - | - | -0.00 |
Weighted Average Shares Outstanding | 115.09 Million | 175.52 Million | 143.04 Million | - | 99.92 Million | 108.58 Million |
Weighted Average Shares Outstanding (Diluted) | 115.09 Million | 175.52 Million | 143.04 Million | - | 99.92 Million | 108.58 Million |
Gross Margin | 0.99 | 1.02 | 0.98 | 2.39 | 0.95 | 0.68 |
EBIT Margin | -0.08 | -3.23 | -0.72 | -24.62 | - | -0.61 |
Profit Margin | -1.62 | -4.20 | -3.46 | -29.55 | -6.28 | -1.20 |
EBITDA | -26.19 Thousand | -883.41 Thousand | -218.98 Thousand | -2.83 Million | - | -170.51 Thousand |
Earnings Before Tax Margin | -1.31 | -3.98 | -1.24 | -16.80 | -5.07 | -1.84 |
SOBR
FDA
ESCORP
JACK
S24
EDRVF